$AYTU
AYTU BIOPHARMA, INC

2022 Q4 Form 10-Q Financial Statement

#000155837022017751 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $26.28M $27.66M $27.45M
YoY Change 13.64% 26.3% 16.89%
Cost Of Revenue $8.986M $9.623M $12.61M
YoY Change -17.0% 1.93% -2.52%
Gross Profit $17.29M $18.03M $14.84M
YoY Change 40.6% 44.77% 40.68%
Gross Profit Margin 65.81% 65.2% 54.07%
Selling, General & Admin $18.58M $17.42M $17.40M
YoY Change 5.48% -0.51% -12.95%
% of Gross Profit 107.43% 96.63% 117.21%
Research & Development $1.710M $1.064M $3.697M
YoY Change -65.24% -49.24% -22.4%
% of Gross Profit 9.89% 5.9% 24.91%
Depreciation & Amortization $400.0K $2.328M $2.246M
YoY Change 0.0% -13.04% -304.37%
% of Gross Profit 2.31% 12.91% 15.13%
Operating Expenses $24.09M $19.69M $21.95M
YoY Change 2.09% -50.98% 1.06%
Operating Profit -$6.793M -$1.653M -$7.104M
YoY Change -39.85% -94.03% -36.38%
Interest Expense $100.0K -$1.100M -$787.0K
YoY Change 400.0% 2650.0% 59.29%
% of Operating Profit
Other Income/Expense, Net $100.0K -$1.228M $999.0K
YoY Change -138.91% 374.13% -86.01%
Pretax Income -$6.693M -$2.881M -$17.70M
YoY Change -42.06% -89.7% -5.54%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.693M -$2.881M -$17.70M
YoY Change -42.04% -89.66% -6.83%
Net Earnings / Revenue -25.47% -10.42% -64.49%
Basic Earnings Per Share -$2.15 -$0.06
Diluted Earnings Per Share -$2.15 -$0.06 -$492.3K
COMMON SHARES
Basic Shares Outstanding 62.43M 62.43M 38.57M
Diluted Shares Outstanding 3.110M 50.36M

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.50M $23.81M $19.36M
YoY Change -44.72% -40.93% -61.01%
Cash & Equivalents $19.50M $23.81M $19.36M
Short-Term Investments
Other Short-Term Assets $624.0K $785.0K $633.0K
YoY Change -55.99% -34.31% -39.02%
Inventory $12.95M $12.87M $10.85M
Prepaid Expenses $11.99M $9.024M $7.375M
Receivables $25.50M $27.90M $21.71M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $70.61M $74.42M $59.93M
YoY Change -19.3% -16.39% -43.05%
LONG-TERM ASSETS
Property, Plant & Equipment $5.019M $5.648M $6.296M
YoY Change -38.33% -33.49% -27.66%
Goodwill $0.00
YoY Change -100.0%
Intangibles $64.99M $69.11M $70.63M
YoY Change -20.11% -17.12% -17.35%
Long-Term Investments
YoY Change
Other Assets $821.0K $829.0K $766.0K
YoY Change 79.65% 78.28% 64.73%
Total Long-Term Assets $70.83M $75.59M $77.69M
YoY Change -48.03% -45.5% -51.57%
TOTAL ASSETS
Total Short-Term Assets $70.61M $74.42M $59.93M
Total Long-Term Assets $70.83M $75.59M $77.69M
Total Assets $141.4M $150.0M $137.6M
YoY Change -36.81% -34.13% -48.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.72M $14.67M $10.99M
YoY Change 26.36% 56.31% -42.94%
Accrued Expenses $41.22M $41.43M $44.19M
YoY Change -18.68% -23.81% -13.86%
Deferred Revenue $100.0K $100.0K $400.0K
YoY Change -50.0% -50.0% 100.0%
Short-Term Debt $7.429M $8.087M $3.813M
YoY Change 3.05% 78.92% -51.94%
Long-Term Debt Due $90.00K $925.0K $96.00K
YoY Change -99.45% -94.4% -99.42%
Total Short-Term Liabilities $67.15M $73.20M $64.44M
YoY Change -33.23% -25.3% -41.12%
LONG-TERM LIABILITIES
Long-Term Debt $14.53M $13.56M $14.28M
YoY Change 11165.89% 8705.19% 7832.78%
Other Long-Term Liabilities $9.781M $9.330M $12.81M
YoY Change 1646.61% 2824.76% 3508.45%
Total Long-Term Liabilities $9.781M $9.330M $12.81M
YoY Change 1646.61% 2824.76% 3508.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.15M $73.20M $64.44M
Total Long-Term Liabilities $9.781M $9.330M $12.81M
Total Liabilities $95.62M $96.09M $91.53M
YoY Change -19.16% -17.32% -28.55%
SHAREHOLDERS EQUITY
Retained Earnings -$294.5M -$291.4M -$288.5M
YoY Change 35.28% 41.32% 61.81%
Common Stock $340.3M $345.3M $334.6M
YoY Change 5.28% 8.69% 5.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.82M $53.91M $46.09M
YoY Change
Total Liabilities & Shareholders Equity $141.4M $150.0M $137.6M
YoY Change -36.81% -34.13% -48.2%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$6.693M -$2.881M -$17.70M
YoY Change -42.04% -89.66% -6.83%
Depreciation, Depletion And Amortization $400.0K $2.328M $2.246M
YoY Change 0.0% -13.04% -304.37%
Cash From Operating Activities -$2.440M -$9.100M -$7.095M
YoY Change -72.34% 139.47% 12.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$5.000K -$42.00K -$41.00K
YoY Change -99.84% -216.67% -49.38%
Cash From Investing Activities -$5.000K $42.00K -$41.00K
YoY Change -99.84% -148.84% -98.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.865M 13.56M -1.117M
YoY Change -128.3% -348.11% -109.45%
NET CHANGE
Cash From Operating Activities -2.440M -9.100M -7.095M
Cash From Investing Activities -5.000K 42.00K -41.00K
Cash From Financing Activities -1.865M 13.56M -1.117M
Net Change In Cash -4.310M 4.451M -8.253M
YoY Change -18.42% -147.65% -365.54%
FREE CASH FLOW
Cash From Operating Activities -$2.440M -$9.100M -$7.095M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2021Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50358134
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25597319
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62429445
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38578825
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 aytu Debt Instrument Prepayment Option Period Of Notice Required
DebtInstrumentPrepaymentOptionPeriodOfNoticeRequired
P5D
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001385818
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Derivative Liability Valuation Technique Extensible List
DerivativeLiabilityValuationTechniqueExtensibleList
http://fasb.org/us-gaap/2022#ValuationTechniqueOptionPricingModelMember
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
46092000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
150000000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
137623000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21897000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
9623000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
9441000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
96000
CY2022Q3 us-gaap Gross Profit
GrossProfit
18032000
CY2022Q2 us-gaap Assets
Assets
137623000
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14667000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10987000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41431000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44187000
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
8087000
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3813000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
925000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8094000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5359000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
73204000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
64442000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
13560000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14279000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9330000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12810000
CY2022Q3 us-gaap Liabilities
Liabilities
96094000
CY2022Q2 us-gaap Liabilities
Liabilities
91531000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62429445
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38578825
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
345253000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
334560000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291353000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-288472000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
53906000
CY2021Q3 us-gaap Gross Profit
GrossProfit
12456000
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-38247
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
AYTU BIOPHARMA, INC.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0883144
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
373 Inverness Parkway
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 206
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
CY2022Q3 dei City Area Code
CityAreaCode
720
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
437-6580
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022Q3 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2022Q3 dei Trading Symbol
TradingSymbol
AYTU
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62429445
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23811000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19360000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27924000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21712000
CY2022Q3 us-gaap Inventory Net
InventoryNet
12871000
CY2022Q2 us-gaap Inventory Net
InventoryNet
10849000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9024000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7375000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
785000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
633000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
74415000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
59929000
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2672000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3025000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2976000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3271000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
69108000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70632000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
829000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
766000
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
75585000
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
77694000
CY2022Q3 us-gaap Assets
Assets
150000000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1064000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1652000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10102000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9297000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7322000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8216000
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19453000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1197000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1537000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
19685000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
40155000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1653000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27699000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1100000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40000
CY2022Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-128000
CY2021Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-219000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1228000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-259000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2881000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27958000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-107000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2881000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27851000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50358134
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25597319
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46092000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1177000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9518000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2881000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53906000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
137568000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1519000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270000
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27851000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
111500000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-2881000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-27851000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2328000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2677000
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19453000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1177000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1519000
CY2022Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-128000
CY2021Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-219000
CY2022Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40560000
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
145000
CY2021Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-161000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
42000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
82000
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
203000
CY2021Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-61000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6212000
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6525000
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2104000
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
178000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1801000
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-279000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3587000
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9888000
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3481000
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3326000
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
72000
CY2021Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-147000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9148000
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3791000
CY2021Q3 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
50000
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-42000
CY2021Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
36000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42000
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86000
CY2022Q3 aytu Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
10416000
CY2021Q3 aytu Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
307000
CY2022Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
793000
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
21000
CY2022Q3 aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
301000
CY2021Q3 aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
2305000
CY2022Q3 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
34791000
CY2021Q3 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
42212000
CY2022Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
30517000
CY2021Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
45626000
CY2022Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
26000
CY2021Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
25000
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
CY2021Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13557000
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5464000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4451000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9341000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19360000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49901000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23811000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40560000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23811000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40308000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
252000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23811000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
565000
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
1688000
CY2022Q3 aytu Warrants Issued
WarrantsIssued
3023000
CY2022Q3 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
146000
CY2021Q3 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
16000
CY2021Q3 aytu Fixed Payment Arrangements Included In Accrued Liabilities
FixedPaymentArrangementsIncludedInAccruedLiabilities
525000
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23800000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27900000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2900000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27900000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-291400000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-288500000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9100000
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3800000
CY2022Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Prior Period Reclassification. </span>Certain prior year amounts in the condensed statements of earnings and statements of cash flows have been reclassified to conform to the current year presentation, including a reclassification made in the presentation of amortization of intellectual property. This was previously included in research and development expenses and is currently recorded in general and administrative expense on the condensed consolidated statements of operations. These reclassifications did not impact operating results or cash flows for the three months ended September 30, 2022 and 2021 or its financial position as of September 30, 2022 or June 30, 2022.</p>
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Management uses estimates and assumptions relating to reporting amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying condensed consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for doubtful accounts, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, the value of goodwill, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, purchase price allocations, the depreciable lives of long-lived assets and classification of warrants equity versus liability. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</p>
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
96000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1768000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
100000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
400000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21897000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21897000
CY2022Q3 aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
100000
CY2021Q3 aytu Inventory Write Down And Impairment
InventoryWriteDownAndImpairment
200000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2113000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1814000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2374000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1838000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8384000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7197000
CY2022Q3 us-gaap Inventory Net
InventoryNet
12871000
CY2022Q2 us-gaap Inventory Net
InventoryNet
10849000
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5408000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5446000
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2736000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2421000
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2672000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3025000
CY2022Q3 us-gaap Depreciation
Depreciation
300000
CY2021Q3 us-gaap Depreciation
Depreciation
400000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
222000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
296000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
160000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
39000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000
CY2022Q3 us-gaap Lease Cost
LeaseCost
403000
CY2021Q3 us-gaap Lease Cost
LeaseCost
357000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2976000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3271000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
238000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
256000
CY2022Q3 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
3214000
CY2022Q2 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
3527000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1252000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1227000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
92000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2090000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
62000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
84000
CY2022Q3 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
3174000
CY2022Q2 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
3497000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M20D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M17D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M23D
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M23D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0754
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0748
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0643
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0643
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
357000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
282000
CY2022Q3 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000
CY2021Q3 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
4000
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
27000
CY2021Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1079000
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
75000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1379000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
87000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
749000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
90000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
46000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3343000
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
162000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
323000
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
8000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3020000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
154000
CY2022Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
19500000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86954000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15050000
CY2022Q3 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
5396000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66508000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
89554000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15050000
CY2022Q3 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
5396000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
69108000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
91620000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16530000
CY2021Q3 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
7058000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68032000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2600000
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94220000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16530000
CY2021Q3 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
7058000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70632000
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4563000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6074000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5934000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5683000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5652000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5552000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
33050000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66508000
CY2022Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1500000
CY2021Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2100000
CY2022Q3 aytu Accrued Saving Offers
AccruedSavingOffers
11801000
CY2022Q2 aytu Accrued Saving Offers
AccruedSavingOffers
12711000
CY2022Q3 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
8080000
CY2022Q2 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
9468000
CY2022Q3 aytu Return Reserve
ReturnReserve
5826000
CY2022Q2 aytu Return Reserve
ReturnReserve
5770000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5679000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4765000
CY2022Q3 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
6832000
CY2022Q2 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
7817000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3213000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3656000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41431000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44187000
CY2022Q3 aytu Fixed Payment Arrangements
FixedPaymentArrangements
12472000
CY2022Q2 aytu Fixed Payment Arrangements
FixedPaymentArrangements
13051000
CY2022Q3 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
706000
CY2022Q2 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
578000
CY2022Q3 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Liability
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationLiability
423000
CY2022Q2 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Liability
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationLiability
396000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3020000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3317000
CY2022Q3 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
803000
CY2022Q2 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
827000
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
17424000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
18169000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8094000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5359000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9330000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12810000
CY2020Q1 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum
16000000.0
CY2020Q1 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Shares Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableSharesMaximum
470000
CY2022Q3 aytu Contingent Value Rights Business Combination Contingent Consideration Milestone Payable Amount Maximum
ContingentValueRightsBusinessCombinationContingentConsiderationMilestonePayableAmountMaximum
5000000.0
CY2022Q3 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
700000
CY2022Q2 aytu Contingent Value Rights Liabilities Fair Value Disclosure
ContingentValueRightsLiabilitiesFairValueDisclosure
600000
CY2022Q3 aytu Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-100000
CY2021Q3 aytu Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentValueRightsGainLossForChangeInFairValueDuringPeriod
100000
CY2022Q3 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Gain Loss For Change In Fair Value During Period
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationGainLossForChangeInFairValueDuringPeriod
0
CY2021Q3 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Gain Loss For Change In Fair Value During Period
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationGainLossForChangeInFairValueDuringPeriod
-200000
CY2021Q3 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Accretion Expense
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationAccretionExpense
100000
CY2022Q3 aytu Business Combination Contingent Consideration And Contingent Consideration Other Than From Business Combination Accretion Expense
BusinessCombinationContingentConsiderationAndContingentConsiderationOtherThanFromBusinessCombinationAccretionExpense
100000
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
3500000
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
1000000.0
CY2022Q1 aytu Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
3500000
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000
CY2022Q1 aytu Debt Instrument Interest Payment Term
DebtInstrumentInterestPaymentTerm
P18M
CY2022Q1 aytu Debt Instrument Interest Payment Extension Term
DebtInstrumentInterestPaymentExtensionTerm
P6M
CY2022Q1 aytu Interest Only Period Further Extension Term
InterestOnlyPeriodFurtherExtensionTerm
P12M
CY2022Q1 aytu Debt Instrument Term Of Trailing Months Revenue
DebtInstrumentTermOfTrailingMonthsRevenue
P12M
CY2022Q1 aytu Debt Instrument Prepayment Fee Percentage
DebtInstrumentPrepaymentFeePercentage
0.030
CY2022Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
600000
CY2022Q1 us-gaap Share Price
SharePrice
1.25
CY2022Q3 us-gaap Loan Processing Fee
LoanProcessingFee
400000
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1537
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
600000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
15000000
CY2022Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
638000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1306000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
154000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14485000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
925000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
13560000
CY2022Q3 aytu Long Term Debt And Finance Lease Liability Maturity Year One
LongTermDebtAndFinanceLeaseLiabilityMaturityYearOne
92000
CY2022Q3 aytu Long Term Debt And Finance Lease Liability Maturity Year Two
LongTermDebtAndFinanceLeaseLiabilityMaturityYearTwo
8395000
CY2022Q3 aytu Long Term Debt And Finance Lease Liability Maturity Year Three
LongTermDebtAndFinanceLeaseLiabilityMaturityYearThree
7304000
CY2022Q3 aytu Long Term Debt And Finance Lease Liability Gross
LongTermDebtAndFinanceLeaseLiabilityGross
15791000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1306000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
925000
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
13560000
CY2022Q2 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue
13051000
CY2022Q3 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityGainLossIncludedInEarnings
-446000
CY2022Q3 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilitySettlements
1025000
CY2022Q3 aytu Fair Value Measurement With Unobservable Inputs Reconciliation Non Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationNonRecurringBasisLiabilityValue
12472000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62429445
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38578825
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
80377
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.61
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M7D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1600
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.34
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
541
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.89
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
78236
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.88
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M1D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
54856
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.61
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M17D
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
100000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1177000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1519000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33531845
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3463256
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21897000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2881000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-27851000
CY2022Q3 us-gaap Assets
Assets
150000000
CY2022Q2 us-gaap Assets
Assets
137623000

Files In Submission

Name View Source Status
0001558370-22-017751-index-headers.html Edgar Link pending
0001558370-22-017751-index.html Edgar Link pending
0001558370-22-017751.txt Edgar Link pending
0001558370-22-017751-xbrl.zip Edgar Link pending
aytu-20220930.xsd Edgar Link pending
aytu-20220930x10q.htm Edgar Link pending
aytu-20220930x10q001.jpg Edgar Link pending
aytu-20220930xex31d1.htm Edgar Link pending
aytu-20220930xex31d2.htm Edgar Link pending
aytu-20220930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
aytu-20220930_cal.xml Edgar Link unprocessable
aytu-20220930_def.xml Edgar Link unprocessable
aytu-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aytu-20220930x10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aytu-20220930_pre.xml Edgar Link unprocessable